Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010231
Filing Date
2020-08-10
Accepted
2020-08-10 17:06:16
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20200630x10q.htm   iXBRL 10-Q 1676439
2 EX-10.1 axsm-20200630xex10d1.htm EX-10.1 240365
3 EX-10.2 axsm-20200630xex10d2.htm EX-10.2 113883
4 EX-31.1 axsm-20200630xex31d1.htm EX-31.1 10864
5 EX-31.2 axsm-20200630xex31d2.htm EX-31.2 10166
6 EX-32.1 axsm-20200630xex32d1.htm EX-32.1 5040
7 EX-32.2 axsm-20200630xex32d2.htm EX-32.2 5019
  Complete submission text file 0001558370-20-010231.txt   5850147

Data Files

Seq Description Document Type Size
8 EX-101.SCH axsm-20200630.xsd EX-101.SCH 37330
9 EX-101.CAL axsm-20200630_cal.xml EX-101.CAL 29050
10 EX-101.DEF axsm-20200630_def.xml EX-101.DEF 103002
11 EX-101.LAB axsm-20200630_lab.xml EX-101.LAB 375361
12 EX-101.PRE axsm-20200630_pre.xml EX-101.PRE 248270
13 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20200630x10q_htm.xml XML 791213
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 201090210
SIC: 2834 Pharmaceutical Preparations